These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3608418)

  • 1. An assessment of the effectiveness of cervical cytology screening in Sheffield.
    Johnson IS; Milner PC; Todd JN
    Community Med; 1987 May; 9(2):160-70. PubMed ID: 3608418
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on a three-county cervical cancer screening project.
    Whitlock NH; Long SE; Kuemmerer JM
    J S C Med Assoc; 1972 Jun; 68(6):237-46. PubMed ID: 4504050
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 4. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved prognosis for cervical cancers due to comprehensive screening.
    Macgregor JE; Fraser ME; Mann EM
    Acta Cytol; 1972; 16(1):14-5. PubMed ID: 4501868
    [No Abstract]   [Full Text] [Related]  

  • 6. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast and cervical cancer screening in the 90's.
    Deloney L
    J Ark Med Soc; 1994 Oct; 91(5):236-8. PubMed ID: 7961312
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present status of mass screening of cancer of the uterine cervix].
    Kutsuzawa T; Moriya S; Okubo H; Sakuragi N; Ichinohe K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):499-504. PubMed ID: 3758914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systematic screening for cervix uteri cancer in the hospital].
    Chabert P
    Rev Fr Gynecol Obstet; 1971; 66(11):647-9. PubMed ID: 5148538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critique of cytology as a mass-screening method].
    Pflanz M
    Fortschr Med; 1974 Mar; 92(9):351-2 passim. PubMed ID: 4819501
    [No Abstract]   [Full Text] [Related]  

  • 14. Economics of screening for cervical cancer.
    Coldman AJ; Anderson GH
    N Z Med J; 1987 Jul; 100(827):425. PubMed ID: 3452069
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of cervical cancer in a women's prison.
    Audet-Lapointe P
    Can Med Assoc J; 1971 Mar; 104(6):509-11. PubMed ID: 5549991
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands.
    Boon ME; de Graaff Guilloud JC
    Acta Cytol; 1981; 25(5):539-42. PubMed ID: 6792845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States.
    Akers AY; Newmann SJ; Smith JS
    Curr Probl Cancer; 2007; 31(3):157-81. PubMed ID: 17543946
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women.
    Aklimunnessa K; Mori M; Khan MM; Sakauchi F; Kubo T; Fujino Y; Suzuki S; Tokudome S; Tamakoshi A; ; Motohashi Y; Tsuji I; Nakamura Y; Iso H; Mikami H; Inaba Y; Hoshiyama Y; Suzuki H; Shimizu H; Toyoshima H; Wakai K; Ito Y; Hashimoto S; Kikuchi S; Koizumi A; Kawamura T; Watanabe Y; Miki T; Date C; Sakata K; Nose T; Hayakawa N; Yoshimura T; Shibata A; Okamoto N; Shino H; Ohno Y; Kitagawa T; Kuroki T; Tajima K
    Jpn J Clin Oncol; 2006 Aug; 36(8):511-8. PubMed ID: 16844732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cervical cytology screening programme in the Thames area. Second and third years of study.
    McIndoe WA
    N Z Med J; 1966 Oct; 65(410):647-51. PubMed ID: 5224361
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of a cancer control programme.
    Knox EG; Woodman CB
    Cancer Surv; 1988; 7(3):379-401. PubMed ID: 3242791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.